Virica's team have landed at BioProcess International in San Diego! Meet us at the Convention Center and let us talk about how we can increase your viral vector production output. We are located in the Exhibition Hall- Poster Board #29
OTTAWA ,Canada– January 24th, 2022 – Virica Biotech Inc., a leading developer of solutions for scaling of viral medicines, today announced it will collaborate with Oxford BioMedica plc (LSE:OXB), a leading gene and cell therapy company, to improve the yield and production efficiency of Oxford Biomedica's next generation lentiviral vector gene therapies using Virica's Viral [...]
Virica is excited to be a part of Advanced Therapies Week, Jan 25th-Jan28th, 2022 at the Miami Convention Center. We are a proud to be a Dynamk Capital portfolio company. Visit us in the Technology of Tomorrow Zone, Booth 11. We look forward to meeting you at Advance Therapies Week!
Please take a moment to watch Virica's Year in Review. We couldn’t have achieved these milestones without you, so thank you.
We now have officially launched our Process Innovation Facility! Take a look at where we enhance the manufacturing of viral medicine.
Watch the grand opening of Virica’s Process Innovation Facility.
